<DOC>
	<DOCNO>NCT00000437</DOCNO>
	<brief_summary>The purpose study determine effectiveness naltrexone ( Revia ) reduce drink smoke patient nicotine alcohol dependence . Individuals randomly assign 12-week trial fix daily dose either naltrexone ( Revia ) nicotine replacement patch placebo . All individual receive weekly cop skill smoking-cessation behavioral therapy . Followup interview conduct 3 6 month treatment determine smoke drinking status persistence dependence symptom .</brief_summary>
	<brief_title>Tobacco Dependence Alcoholism Treatment ( Nicotine Patch/Naltrexone )</brief_title>
	<detailed_description />
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Meets criteria alcohol dependence nicotine dependence . Expresses desire cut stop drinking smoking . Currently meet criterion dependence substance alcohol nicotine . Any history opiate dependence evidence current opiate use . Significant medical disorder increase potential risk interfere study participation . Liver function test 3 time normal elevated bilirubin . Females pregnant , nursing , use reliable method birth control . Meets criteria major psychiatric disorder need currently undergoing drug therapy . Inability understand and/or comply provision protocol consent form . Treatment investigational drug previous month . Chronic treatment narcoticcontaining medication previous month . Sensitivity drug evidence adverse drug experience especially narcotic contain analgesic opioid antagonist . Current treatment disulfiram ( Antabuse ) nicotine replacement therapy . More 6 week abstinence .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2010</verification_date>
</DOC>